Bond Labs Reports Record 2012 Results Revenue Increases 50%, Net Income Increases 673%
OMAHA, Neb., Apr 01, 2013 (BUSINESS WIRE) -- Bond Laboratories, Inc. (OTCBB:BNLB) ("Bond Labs"), an international provider of innovative and proprietary nutritional supplements for health conscious consumers, announced year end results for the fiscal year ended December 31, 2012. Revenue for the twelve months ended December 31, 2012 increased to $18.1 million as compared to $12.1 million for the comparable period last year, an increase of $6.0 million, or 49.6%. Net income for the twelve months ended December 31, 2012 increased to $2.5 million as compared to $0.3 million for the comparable period last year, an increase of $2.2 million, or 672.8%. Basic and fully-diluted earnings per share for the twelve months ended December 31, 2012 were $0.03 and $0.03, respectively, as compared to $0.0 and $0.0 for the comparable period last year. Net income for the year ended December 31, 2012 included a $0.6 million income tax benefit. Without the income tax benefit, net income for the twelve months ended December 31, 2012 increased to $1.9 million as compared to $0.3 million for the comparable period, an increase of $1.5 million or 471.6%. Additional key highlights include the following:
-- Over the last three fiscal years revenue has increased by $10.0 million from a base of $8.1 million in 2010 to $18.1 million in 2012; over that same time period net income improved more than $5.7 million from a net loss of $3.2 million in 2010 to net income of $2.5 million in 2012.
-- Bond remains debt free, other than $437,089 under a revolving credit line.
-- Bond began its major push into international markets during 2012, beginning with Australia with additional markets scheduled to launch in 2013.
"Our strategic initiatives remain focused on both expanding the number of retail locations and increasing average revenue per location," commented John Wilson, CEO of Bond Labs. "To that end, we remain dedicated to developing and marketing high-quality and innovative products that address the needs of our loyal customer base. The expansion of our reach into international markets, while still a relatively small percent of our total revenue, represents a compelling opportunity that I believe will be a critical driver of Bond Labs' future growth. 2012 was truly a break-out year for Bond Labs and I, along with the rest of the management team, am truly excited about our prospects and initiatives for 2013," Mr. Wilson concluded.
About Bond Labs
Bond Laboratories is a manufacturer of innovative and proprietary nutritional supplements for health conscious consumers. The Company produces and markets products through its NDS Nutrition division. NDS' products number over 50 brands of energy, sports, and dietary supplements. These products are sold directly through specialty health and nutrition retailers, and are included among the top-selling products at GNC(R) franchises. Bond Labs is headquartered in Omaha, Nebraska. For more information, please visit http://www.bond-labs.com.
Safe Harbor
Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby. The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management as well as assumptions made by and information currently available to the Company or its management. The company does not undertake any responsibility to update the forward-looking statements contained in this release.
Market Data 
Markets 
AI
